Clinical Trials

Parachute® Ventricular Partitioning Device Clinical Trial

The Structural Heart Team continues to pursue newer technologies and clinical trials. Saint Joseph Hospitalis the first hospital in Kentucky to have access to the Parachute (percutaneous ventricular restoration in chronic heart failure due to ischemic heart disease) clinical trial, a pivotal trial to establish efficacy and long-term safety of the Parachute implant system. The first-of-its-kind Parachute Ventricular Partitioning Device is a minimally invasive treatment for patients with heart failure caused by damage to the heart muscle following a heart attack. Clinical data demonstrates improved overall cardiac function and quality of life for patients treated with the Parachute device.

Through a small catheter inserted in the femoral artery, the Parachute implant is deployed in the left ventricleto partition the damaged muscle, excluding the non- functional heart segment from the healthy, functional segment to decrease the overall volume of the left ventricle and restore its geometry and function. The Structural Heart Team performs this minimally invasive procedure in the catheterization lab under conscious sedation.